Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (31)

2024

  1. Effects of comorbidities (chronic illness) on hospitalization and mortality risks: Available to clinicians through an app

    Technology in Healthcare: Introduction, Clinical Impacts, Workflow Improvement, Structuring and Assessment (Now Publishers), pp. 88-102

  2. General learnings from the horizon 2020 project BigMedilytics

    Technology in Healthcare: Introduction, Clinical Impacts, Workflow Improvement, Structuring and Assessment (Now Publishers), pp. 341-360

  3. Monitoring sepsis patients in the emergency department: The use of a real-time location system

    Technology in Healthcare: Introduction, Clinical Impacts, Workflow Improvement, Structuring and Assessment (Now Publishers), pp. 266-279

2023

  1. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)

    Journal of hypertension, Vol. 41, Núm. 12, pp. 1874-2071

  2. Corrigendum to “Genetic interaction in the association between oxidative stress and diabetes in the Spanish population” [Free Radic. Biol. Med. 205 (2023) 62–68, (S0891584923004719), (10.1016/j.freeradbiomed.2023.05.030)]

    Free Radical Biology and Medicine

  3. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  4. Genetic interaction in the association between oxidative stress and diabetes in the Spanish population

    Free Radical Biology and Medicine, Vol. 205, pp. 62-68

  5. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

    Nature Medicine, Vol. 29, Núm. 11, pp. 2885-2901

  6. High miR-126-3p levels associated with cardiovascular events in a general population

    European Journal of Internal Medicine, Vol. 113, pp. 49-56

  7. Neurohumoral and Autonomic Regulation of Blood Pressure

    Pediatric Hypertension: Fifth Edition (Springer International Publishing), pp. 3-19

  8. Persistence and determinants of blood pressure phenotypes according to office and ambulatory blood pressure measurements in youth

    Hypertension Research, Vol. 46, Núm. 5, pp. 1257-1266

  9. Rab3A/Rab27A System Silencing Ameliorates High Glucose-Induced Injury in Podocytes

    Biology, Vol. 12, Núm. 5

  10. Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based Combinations

    High Blood Pressure and Cardiovascular Prevention, Vol. 30, Núm. 2, pp. 109-121

  11. Towards a personalized health care using a divisive hierarchical clustering approach for comorbidity and the prediction of conditioned group risks

    Health Informatics Journal, Vol. 29, Núm. 4

2022

  1. COMBINED EXOSOMAL AND PLASMA NON-CODING RNA SIGNATURE ASSOCIATED WITH URINARY ALBUMIN EXCRETION IN HYPERTENSION

    Journal of hypertension, Vol. 40, pp. e82

  2. DECREASED URINARY LEVELS OF SIRT1 AS NON-INVASIVE BIOMARKER OF EARLY RENAL DAMAGE IN HYPERTENSION

    Journal of hypertension, Vol. 40, pp. e249

  3. Incidence and impact of atrial fibrillation in heart failure patients: real-world data in a large community

    ESC Heart Failure, Vol. 9, Núm. 6, pp. 4230-4239

2021

  1. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

    eLife, Vol. 10

  2. Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation

    Frontiers in Cardiovascular Medicine, Vol. 8

2020

  1. Repositioning of the global epicentre of non-optimal cholesterol

    Nature, Vol. 582, Núm. 7810, pp. 73-77